Additional investigation using the TRRUST database on Metascape indicated that Nfe2l2 plays a crucial role as a regulatory transcription factor in the MPTP_BFT versus MPTP comparison group, suggesting that activating Nfe2l2 might be a beneficial approach for PD treatment. This evidence concerns the gene NFE2L2 and Parkinson disease.